FUTURE OF HEALTHCARE

Concord Health Partners Adds Healthcare Veteran Brian Gragnolati as Executive Partner

Concord Health Partners | July 12, 2022 | Read time : 2 min

Concord Health

Concord Health Partners a healthcare focused investment firm, announced that Brian Gragnolati has joined as Executive Partner. Gragnolati currently serves as President and CEO of Atlantic Health System. During his tenure at Atlantic Health System, he also served as Chairman of the Board of Trustees of the American Hospital Association.     

The addition of Gragnolati as Executive Partner further expands Concord's team of healthcare sector specialists, adding the network, knowledge and insights of an experienced CEO and a nationally recognized leader in the provider industry. Gragnolati will work with James Olsen, Founder and Managing Partner, and other members of the Concord team to source new investment opportunities, support management teams and accelerate the growth of portfolio companies through commercial introductions across the Concord network of strategic relationships. 

"We are thrilled to add someone with Brian's experience, knowledge and expertise to Concord's executive team. We established Concord with the goal of creating lasting partnerships with strategic investors to help drive the adoption of our portfolio company technologies and solutions across a broad universe of healthcare providers and payors. Brian brings unique perspective from his roles as a health system chief executive officer and at the AHA, and has distinguished himself as a valuable partner to Concord in those roles. We look forward to leveraging his insights and network as he helps identify new opportunities and accelerate growth at our portfolio companies as Executive Partner." 

James Olsen, Founder and Managing Partner at Concord

"In working with Concord over the years, it was clear that the Firm has developed a powerful model for healthcare investing. Concord has become a leader in identifying innovative companies and partnering with them to drive growth," said Gragnolati. "I am excited at the opportunity to work even more closely with the Concord team and their portfolio companies to help them continue to deliver solutions that lower costs, improve quality and expand access to care." 

Gragnolati has served as President and CEO of Atlantic Heath System since 2015, and is the former Chairman of the Board of Trustees of the AHA.  Prior to his tenure at Atlantic Health, Brian served as Senior Vice President at Johns Hopkins Medicine. He previously held executive positions at Wellspan Health, University of Vermont Medical Center and Baystate Medical Center in Springfield, MA. As a nationally respected voice in health care, Mr. Gragnolati played a key role in public relations and media communications during the COVID pandemic. He regularly appears on CNBC, MSNBC, Bloomberg and other media outlets to share his insight on the nation's most pressing health concerns. He has been honored by Modern Healthcare as one of the 100 most influential people in healthcare. He serves on the Board of Directors of Lakeland Bancorp, Inc. and Lakeland Bank. Gragnolati holds a bachelor's degree in Health Systems Analysis from the University of Connecticut, an MBA from Western New England College and an Executive Leadership Certificate from the JFK School at Harvard University. 

About Concord Health Partners
Concord Health Partners is a healthcare focused investment firm with a strategic model that optimizes the alignment of interests between investors and portfolio companies. Concord has developed a broad network of  strategic investors that contribute expertise and resources, and serve as potential commercial partners to portfolio companies. Concord is primarily focused on investing in healthcare companies that have the potential to enhance the value of care through products, services, technologies and solutions that lower costs, improve quality and expand access to care. 

Spotlight

The aim of this report, which can be considered a follow-up to the 2017 OECD report, is to examine the economics of patient safety specifically in primary and ambulatory care given (a) the growing importance of this setting in maintaining population health against the background of health and financial challenges, and (b) its critical role in ensuring the sustainability and resilience of the broader health system.

Spotlight

The aim of this report, which can be considered a follow-up to the 2017 OECD report, is to examine the economics of patient safety specifically in primary and ambulatory care given (a) the growing importance of this setting in maintaining population health against the background of health and financial challenges, and (b) its critical role in ensuring the sustainability and resilience of the broader health system.

Related News

HEALTH TECHNOLOGY

Kaia Health Raises the Bar for Automated Mobility Assessments with Launch of 3D Computer-Vision MSK Solution

Kaia Health | August 19, 2022

Kaia Health, the largest global digital therapeutics company on a mission to deliver the most effective digital therapies – anytime, anywhere, announced the addition of 3D full body mobility assessments, raising the bar for the standard of care delivery with motion analysis technology. The technology creates a full 3D model of the body, removing the need for restrictive placement of the phone, and tracks the most important skeletal structures with an eye to what clinical teams care about most and with unparalleled precision. Tracking the most relevant points of any company in the world with high precision, allows continuous detection of subtle displacements and mobility limitations in the back, hip, knee, and ankles, something that neither in-person physical therapy or other virtual options can achieve. Using only a smartphone or tablet, there is no need for sensors or additional devices. Using this quantitative data, members are provided with a personalized physical therapy program, real-time feedback, and specific exercises to help counteract mobility limitations. The technology also enables improved care design by the care team, a better understanding of the member’s progression over time, and as a result, improved clinical outcomes. “With this new capability, we are able to deliver the most effective digital therapy experience by analyzing movement in real-time and providing a tailored program for each of our members. We are proud to be a world-leader in improving access to great care by delivering this innovative, clinically-validated solution to our members, driving better clinical outcomes and an optimal ROI at scale for our health plan and employer partners.” Simon Hayhurst, chief product officer of Kaia Health The global market for computer vision applied to healthcare is expected to reach $5.15 billion by 20261, and in recent months, the technology has seen rapid adoption among companies that provide MSK solutions. Kaia Health is a pioneer in MSK technology and computer vision, having introduced it in 2018 with their exercise feedback and assessments capabilities. A study published in the peer-reviewed Journal of Medical Internet Research previously demonstrated Kaia Health’s technology to be as accurate as a physical therapist in suggesting exercise corrections. About Kaia Health Kaia Health is the world’s largest digital therapeutics company on a mission to empower millions of people to live their healthiest life. Our evidence-based treatments, covering a range of conditions, including musculoskeletal pain and COPD, are powered by proprietary motion analysis technology and clinical expertise. No sensors or wearables, Kaia’s programs need only a smartphone to deliver the most accessible, effective, and equitable experience for all. Eleven randomized clinical trials have shown Kaia’s effectiveness and safety to be as good as traditional care with up to 80% reduction in cost. Kaia Health is a member of the Digital Therapeutics Alliance (DTA) and is headquartered in NY and Munich. Kaia partners with leading health plans, employers, and providers, covering 60+ million lives around the world.

Read More

HEALTH TECHNOLOGY

Smith+Nephew introduces smart glasses into the operating room to enable remote technical support for UK surgeons during procedures

Smith & Nephew | July 11, 2022

Smith+Nephew the global medical technology company, announces a partnership with Rods&Cones to provide smart surgery glasses and digital remote assistance to customers. By providing customers with smart surgery glasses, Smith+Nephew representatives can 'see' through the eyes of the surgeon, instrumentalist nurse, or any healthcare professional using them, enabling continuous remote support before, during, and after surgical interventions. Initially used in the UK to support the NHS and other customers, this solution allows Smith+Nephew to increase its ability to offer technical support for safe and effective use of its products at the right time from anywhere in the world. The increased complexity of surgery, advancement of technologies, and need for productivity and efficiency is enabled by ensuring a specialist is available remotely to give best possible expertise exactly when they need it, in the least disruptive way. "I am delighted that we have agreed to partner with one of the most innovative companies in the area of remote surgical support," said Simon Tarry, Managing Director of Smith+Nephew's UKI/Nordics region. "This new partnership will enable our team to deliver the highest possible expertise exactly when our customers and patients need it. At the same time, I believe enhancing our ability to support our customers remotely serves patient safety and sustainability to great effect." The multi-year agreement with Rods&Cones allows Smith+Nephew to scale its remote support capability for customers, enabling connectivity with specialist surgeons during minimally invasive surgery. The MIS Kit connects seamlessly to a secure Rods&Cones Remote Expert interface, which allows the user to follow and attend a surgery just as if standing in the OR, but with the exact view of the surgeon or other healthcare professional. "We are thrilled to work with such a great company as Smith+Nephew. The achievements they have made in the MedTech industry, especially within the sphere of repair, regeneration and replacement of soft and hard tissue has been awe-inspiring. This partnership between Smith+Nephew and Rods&Cones will be a great step forward and together we will change healthcare for the better." Bruno Dheedene, CEO and Founding Partner of Rods&Cones About Smith+Nephew Smith+Nephew is a portfolio medical technology business focused on the repair, regeneration and replacement of soft and hard tissue. We exist to restore people's bodies and their self-belief by using technology to take the limits off living. We call this purpose 'Life Unlimited'. Our 18,000 employees deliver this mission every day, making a difference to patients' lives through the excellence of our product portfolio, and the invention and application of new technologies across our three global franchises of Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Founded in Hull, UK, in 1856, we now operate in more than 100 countries, and generated annual sales of $5.2 billion in 2021. Smith+Nephew is a constituent of the FTSE100. The terms 'Group' and 'Smith+Nephew' are used to refer to Smith & Nephew plc and its consolidated subsidiaries, unless the context requires otherwise. About Rods&Cones Rods&Cones' purpose is to be a catalyst of change in healthcare to improve people's lives. The company provides a remote assistance service used to connect medical experts worldwide. With their state-of-the-art technological devices and a digital remote assistance platform, users can connect safely with surgeons, product specialists, or other medical professionals anywhere in the world, in real-time. Rods&Cones was founded in 2017 by two brothers, Bruno and Jan Dheedene. Based in Amsterdam, The Netherlands, the company has now become a leading international supplier of remote surgical assistance services.

Read More

FUTURE OF HEALTHCARE

Allina Health and Owens & Minor Expand Partnership and Announce New Strategic Collaboration

Owens & Minor, Inc. | August 10, 2022

Owens & Minor, Inc. a leading global healthcare solutions company, and Allina Health, a not-for-profit healthcare system dedicated to enhancing the health of individuals, families and communities throughout Minnesota and western Wisconsin, today announced their renewed partnership and a new strategic collaboration to create a unique integrated service model for supply chain resiliency. The integrated service model is an evolution of the 20-year partnership between Allina Health and Owens & Minor. At the heart of the model is an integrated service center that will serve as the hub and central command for supply chain operations, combining communications, fulfillment, inventory management and distribution into an end-to-end solution built specifically for the needs of Allina Health’s hospital and clinical care network, including its 6,000 associated and employed physicians. “Allina Health believes that deepening our successful relationship with Owens & Minor will elevate our ability to ensure that our providers and clinical staff have the products they need, when they need them. Further combining our collective strengths is key to our vision for exploring creative, innovative ways to improve our supply chain operations. We are excited by what this new phase of our 20-year strategic partnership with Owens & Minor will bring.” Thomas M. Lubotsky, Vice President of Supply Chain, Allina Health Owens & Minor’s 140 years of supply chain expertise and innovative approach will serve as the backbone of Allina Heath’s supply chain operations, merging the company’s proprietary product portfolio, robust logistics capabilities, distribution, and technology services into a shared bespoke solution with improved data transparency, communication and inventory management capabilities that lower inventory costs. “We welcome the opportunity to work more closely with a partner as forward-thinking as Allina Health to not only drive greater efficiencies, but also to collaborate on new ways to support the continued health of their supply chain operations,” commented Jeff Jochims, EVP, Chief Operating Officer and President, Products and Healthcare Services, Owens & Minor. “We look forward to continuing and growing our long and successful partnership.” About Allina Health Allina Health is dedicated to the prevention and treatment of illness and enhancing the greater health of individuals, families and communities throughout Minnesota and western Wisconsin. A not-for-profit health care system, Allina Health cares for patients from beginning to end-of-life through its 90+ clinics, 10 hospitals, 15 retail pharmacies, specialty care centers and specialty medical services, home care, and emergency medical transportation services. About Owens & Minor Owens & Minor, Inc. is a Fortune 500 global healthcare solutions company integrating product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. Owens & Minor drives visibility, control and efficiency for patients, providers and healthcare professionals across the supply chain with proprietary technology and solutions, an extensive product portfolio, an Americas-based manufacturing footprint for personal protective equipment (PPE) and surgical products, as well as a robust portfolio of products and services for patients managing chronic and acute conditions in the home setting. Operating continuously since 1882 from its headquarters in Richmond, Va., Owens & Minor is a 140-year-old company powered by more than 20,000 global teammates.

Read More